Tag: big pharma

Hydroxychloroquine

If you’ve watched the news lately, you might be under the impression that a medicine President Trump touted as a possible game changer against coronavirus — has been debunked and discredited. Two divergent views of the drug, hydroxychloroquine, have emerged: the negative one widely reported in the press and another side you’ve probably heard less about. Never has a discussion about choices of medicine been so laced with political overtones. Today, how politics, money and medicine intersect with coronavirus.

Keep reading

Private Investigators Say Several People Murdered Canadian Billionaire Couple Barry and Honey Sherman

Private investigators in Canada believe that a prominent billionaire couple found dead in their Toronto mansion last month were murdered by multiple assailants, pouring cold water on the theory that their deaths were a result of a murder-suicide.

Canada’s CBC News reported the private investigators’ findings on the couple’s mysterious killing Saturday, citing an unnamed source familiar with a parallel investigation into their deaths.

Police had earlier deemed the deaths of Barry Sherman, 75, and his wife Honey, 70, “suspicious” after a realtor discovered the bodies dangling from a railing near their basement swimming pool on December 15. A coroner’s report determined the couple had died from a form a strangulation called “ligature neck compression.”

Keep reading

Vaccine Execs Rake In $1 Billion In Stock Sales As Positive Headlines Boost Shares

With the race to find a vaccine for COVID-19 in full effect, biotech executives and other insiders from at least 11 companies have made hand over fist – raking in over $1 billion in stock sales after announcing positive developments, according to the New York Times.

In some cases, company insiders are profiting from regularly scheduled compensation or automatic stock trades. But in other situations, senior officials appear to be pouncing on opportunities to cash out while their stock prices are sky high. And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. -NYT

Keep reading

Covid-19 Vaccines With ‘Minor Side Effects’ Could Still Be Pretty Bad

On Monday, vaccine researchers from Oxford University and the pharmaceutical company AstraZeneca announced results from a “Phase 1/2 trial,” suggesting their product might be able to generate immunity without causing serious harm. Similar, but smaller-scale results, were posted just last week for another candidate vaccine produced by the biotech firm Moderna, in collaboration with the U.S. National Institutes of Health.

As both these groups and others push ahead into the final phase of testing, it’s vital that the public has a clear and balanced understanding of this work—one that cuts through all the marketing and hype. But we’re not off to a good start. The evidence so far suggests that we’re getting blinkered by these groups’ PR, and so seduced by stories of their amazing speed that we’re losing track of everything else. In particular, neither the mainstream media nor the medical press has given much attention to the two vaccines’ potential downsides—in particular, their risk of nasty adverse effects, even if they’re not life-threatening. This sort of puffery doesn’t only help to build a false impression; it may also dry the tinder for the future spread of vaccine fear-mongering.

Keep reading